MedPath

Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)

Recruiting
Conditions
Neurocognitive Disorders
Interventions
Other: Series of cognitive tasks during a semi-automated call
Registration Number
NCT05943834
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

PLATA aims to develop an algorithm to identify vocal biomarkers of Alzheimer's dementia.

Using data collected as part of routine care, speech patterns will be compared to known biomarkers of Alzheimer's disease, such as amyloid 1-42 and p-Tau in CSF (cerebrospinal fluid).

If biomarkers of speech can be identified in Alzheimer's disease, it is possible that patients and research participants will no longer need to undergo need to undergo the intensive and invasive baseline biomarker methods currently used, such as lumbar punctures and PET scans.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age ≥ 50 years
  • Diagnosis relevant biomarker and neuropsychological data already available
  • Cognitively healthy to very mild dementia (CDR score max. 0.5)
  • Sufficient knowledge of the study language to understand study information, non opposition form,and questionnaires
  • Expression of non opposition
Exclusion Criteria
  • Hearing problems
  • Patient protected by law, under guardianship or curator ship, or not able to participate in a clinical study according to the article L.1121-16 of the French Public Health Code

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with a minor or major neurocognitive disorderSeries of cognitive tasks during a semi-automated callEvery patient will receive one semi-automated phone call, during the call a series of cognitive tasks will be performed. Each task will be recorded in a secondary audio stream which records the participant responses to allow for deep speech analysis of performance on these tasks
Primary Outcome Measures
NameTimeMethod
Build and validate speech-based machine learning models for relevant Phenotype detection through access to phenotyped patients from reference memory center.20 minutes

Speech biomarker algorithm(s)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath